A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells

Lung cancer is the leading cause of cancer-related death in both men and women. Lung cancer contains a small population of cancer cells with stem-like features known as cancer stem cells (CSCs). CSCs are often more resistant to current therapeutic treatments. Thus, it is urgent to develop a novel ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiyang, Guo, Yuming, Wang, Jing, Zhu, Hai, Han, Yuqing, Jin, Mingji, Wang, Jun, Zhou, Congya, Ma, Junfeng, Lin, Qingcong, Wang, Zhaoyi, Meng, Kun, Fu, Xueqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216713/
https://www.ncbi.nlm.nih.gov/pubmed/27281614
http://dx.doi.org/10.18632/oncotarget.9783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216713/
https://www.ncbi.nlm.nih.gov/pubmed/27281614
http://dx.doi.org/10.18632/oncotarget.9783

Ejemplares similares